Buzzkill Labs has developed ToxiTrace™, an innovative testing solution designed to address the challenges employers face in detecting marijuana use during work hours. This fully-automated lab-in-a-box system can be easily installed and operated in occupational health clinics and drug testing centers. ToxiTrace™ utilizes advanced lab-standard chromatography techniques to effectively isolate and identify psychoactive THC from oral fluid samples, distinguishing it from nonpsychoactive cannabinoids like CBD. This capability is crucial, as traditional testing methods have struggled to provide the specificity and sensitivity required for accurate detection of recent marijuana use.

The ToxiTrace™ system requires only a 2mL collection of oral fluid, which is a federally recognized sample type, and delivers results in approximately 20 minutes. This rapid turnaround allows employers to identify workday marijuana use in real-time, without the delays associated with conventional lab-based testing. By focusing on psychoactive THC, ToxiTrace™ enables employers to make informed decisions regarding employee conduct during work hours, while respecting the legal use of marijuana outside of work. This technology represents a significant advancement in workplace drug testing, providing a timely and reliable solution for modern employers.

United States

Market opportunities created by evolving legislation legalizing recreational use of cannabis is generating a significant need for advances in rapid and accurate drug testing technology. Buzzkill Labs is developing next generation technology that will combine patented noninvasive sample collection methodology with scientifically validated laboratory detection and quantitation technology. Buzzkill Labs products will address the growing need for:SAFETY IN THE WORKPLACESUSPECTED IMPAIRED DRIVING BY LAW ENFORCEMENTFAST AND ACCURATE TESTING BY MEDICAL AND DRUG TREATMENT CENTERS

Buzzkill Labs

Company Details